Duke Revisits Conflict of Interest Policy for Physicians, Drug Companies

Advertisement

Duke University Medical Center in Durham, N.C., is revising its conflict of interest policies to increase transparency between physicians and drug companies, according to a Herald-Sun report.

The revision follows a report by ProPublica, a non-profit investigative journalism organization, which listed approximately 17,700 physicians from across the country along with the compensation disclosures from drug companies in 2009 and 2010. 

In North Carolina, 16 physicians were paid more than $100,000 — and all except one taught and/or practices with Duke Medicine and UNC Hospitals, according to a Herald-Sun report.

Duke’s new conflict of interest policy will be university-wide, applying to physicians and academic faculty. Duke officials say the updated policy is on schedule, but the lengthy process requires review of numerous academic committees.

Read the Herald-Sun report on the hospital conflict of interest policies at Duke University Medical Center.

Read more about Duke University Medical Center:

– $800M Expansion Begins at Duke University Health System

– Duke Earns Praise for Community Care Model in North Carolina

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.